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Questions 
• What are the social and cultural challenges related to the equitable roll-out, distribution 
and access of COVID-19 vaccines, tests and treatments?  
• How does this impact upon excluded and marginalised groups (e.g. women and girls, 
people with disabilities, LGBTI communities)?  




2. Equitable COVID-19 vaccine roll-out, distribution, and access 
3. Social and cultural challenges related to COVID-19 vaccine roll-out, distribution, and access 
4. Impacts of these challenges on excluded and marginalised groups 








Social inclusion is an important determinant of health. The current COVID-19 epidemic is both a 
health and societal issue (Rajan et al., 2020). Therefore, group historically excluded and 
marginalised in terms of healthcare will suffer if COVID-19 vaccines, tests, and treatments are to 
be delivered equitably. 
This rapid review is exploring the social and cultural challenges related to the roll-out, 
distribution, and access of COVID-19 vaccines, tests, and treatments. It highlights how these 
challenges impact certain marginalised groups. Case studies are taken from sub-Saharan Africa 
(the Democratic Republic of Congo, South Africa), with some focus on South East Asia 
(Indonesia, India) as they have different at-risk groups. Lessons on this issue can be learned 
from previous pandemics and vaccine roll-out in low- and mid-income countries (LMICs). 
Key points to highlight: 
• Successful COVID-19 vaccine roll-out will only be achieved by ensuring effective 
community engagement, building local vaccine acceptability and confidence, and 
overcoming cultural, socio-economic, and political barriers that lead to mistrust and 
hinder uptake of vaccines (Burgess et al., 2020).  
• Main challenges of social/cultural issues related to equitable roll-out of COVID-19 
vaccines, tests, treatments include lack of acceptance, and discrimination.  
• “Hard-to-reach” groups focus on vaccine delivery (high levels of demand, but face low 
supply), whereas “hard-to-vaccinate” groups centres on vaccine uptake and acceptance 
(low levels of demand despite high supply) (Ozawa et al., 2019). Both groups are 
impacted by social challenges, resulting in adverse health outcomes (including those 
with co-morbidities) and socio-economic inequalities, e.g. due to lockdowns. 
• However, the difference between “hard-to-reach” and “hard-to-vaccinate” populations is 
unclear based on current literature (Ozawa, 2019). For example, people living with 
disabilities (PLWD) can be hard-to-reach (e.g. due to poverty, their living circumstances, 
or lack of mobility) and hard-to-vaccinate (e.g. due to mistrust of health systems). A more 
accurate term for these groups would be “hardly reached” (Dodds & Fakoya, 2020). 
• COVID-19 has had a disproportionate impact on racial and ethnic groups in high income 
countries such as the UK and USA. However, there is a lack of similar data from LMICs. 
UN data shows that COVID-19 has a disproportionate impact on LGBTQI persons 
(OHCHR, 2020c). However, the literature on this is also limited. Older people have also 
been excluded for socio-economic reasons, e.g. during lockdowns. 
• Certain minority groups may be more at risk of being left behind in COVID-19 
vaccination programmes, as hard-to-reach groups were at a greater risk of exposure and 
transmission of Ebola, for example the BaTwa indigenous group due to gender norms 
and discrimination on basis of ethnic group (Lenhardt, 2020). This also made them hard-
to-vaccinate.  
• Main demand side factors that influenced vaccine uptake was religious beliefs and lack 
of trust/ misinformation about COVID-19 (de Figueiredo et al., 2020). 
• Rafaeli & Hutchinson (2020) found that girls’ education, social protection, unintended 
pregnancies, access to health services, poverty, livelihood, land rights, women’s and 
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girls’ informal employment, food security and nutrition, female health workforce, and 
access to WASH in sub-Saharan Africa were all affected by COVID-19.  
• Assessments of vaccination coverage for the general population may not be sufficient 
(Weiss et al., 2009: 362). Spatial heterogeneity (i.e. uneven distribution within an area) 
has been used to determine the success of immunisation programmes, as well as risk of 
disease persistence (Brownwright et al., 2017). Gap analysis, such as that by EBODAC, 
can identify vaccine roll-out supply and demand needs and adherence. 
• Lessons learned: There has been disagreement in the Médecins Sans Frontières (MSF) 
and World Health Organization (WHO) vaccine distribution, e.g. Ebola responses. The 
roll-out of the H1N1 or swine flu vaccine in 2009 was plagued by shortages and 
miscommunication, which led to a drop in public confidence. A lot of lessons learned 
about roll-out involve communication - including that the government should under-
promise what it can do and then over-deliver. Any campaign must aim to create trust, and 
involve local communities in planning processes (IRC, 2021). One important lesson from 
Ebola is that understanding social dynamics is essential to designing robust 
interventions, and should be a priority in public health and emergency planning 
(Wilkinson et al., 2017). 
This review draws mostly on grey and academic literature, including COVID-19 perspectives. 
However, there are potential factors in social inclusion that may never have been fully studied in 
relation to mass immunisation campaigns and, therefore, do not appear in any literature 
(published or unpublished) (Weiss et al., 2009: 364). In terms of terminology, immunisation (a 
process by which a person becomes protected against a disease through vaccination) is often 
used interchangeably with vaccination (the act of introducing a vaccine into the body to produce 
immunity to a specific disease). In terms of availability of data, the majority of data related to 
inclusion in previous pandemics from LMICs is available for Ebola.  
2. Equitable COVID-19 vaccine roll-out, distribution, and 
access 
According to international human rights standards, all people have an equal right to the highest 
attainable standard of physical and mental health, which includes access to health care, as well 
as to the underlying determinants of good health (Willen et al., 2017). The United Nations (UN) 
states that “it is imperative that access to COVID-19 vaccines and treatment is provided to all 
without discrimination and prioritized for those who are most exposed and vulnerable to 
the risk of COVID-19” (OHCHR, 2020a). However, discussions continue about the ethical 
challenges of ensuring fair access to COVID-19 vaccines within and across countries, and 
which groups should be prioritised (Burgess et al., 2020).  
People in vulnerable situations who are often neglected from health services, goods and 
facilities, include: women; indigenous peoples; people living with disabilities (PLWD); older 
persons; minority communities; internally displaced people (IDP); persons in overcrowded 
settings and in residential institutions; people in detention; homeless persons; migrants and 
refugees; people who use drugs, as well as lesbian, gay, bisexual, transgender, 
queer/questioning, and intersex (LGBTQI) persons (OHCHR, 2020a). Many of them may have 
experienced poverty, and find themselves in situations where they are most likely to be 
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exposed to the risk of contagion; yet are the least likely to be protected from COVID-19, or 
supported by adequate and timely tests and health services (OHCHR, 2020b).  
To ensure the equitable distribution of COVID-19 vaccine doses to help protect the most-at-risk 
groups - i.e. those with greater chances of being infected with COVID-19 or of getting very sick - 
in all participating countries, Gavi- the Vaccine Alliance and the World Health Organization 
(WHO) have developed a framework through the COVID-19 Vaccines Global Access (COVAX) 
Facility. COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. 
Several low- and middle-income countries (LMICs) will get their vaccines through COVAX, 
including many African countries that would not otherwise be covered.1 COVAX will offer vaccine 
doses for at least 20% of these countries' populations.2 However, the reality may be much lower, 
so all vulnerable groups may not be reached (IRC, 2021). Few south east Asian countries 
(Mongolia, Myanmar, Nepal) are seeking assistance from the Gavi and COVAX programmes to 
acquire vaccines (ASEAN Briefing, 2021): 
Case study: Indonesia 
Indonesia is due to start a mass inoculation campaign with Chinese vaccine Sinovac in February 
2021, and will also be seeking assistance from the COVAX programme.3 According to the Health 
Ministry’s Disease Control and Prevention, instead of vaccinating older people in the first phase, 
after frontline workers and support staff, vaccinations will only be provided to citizens aged 18-
59 years. This is because they make up the public work force, which needs to be protected first 
to boost the economy.4 However, it puts older people at risk of becoming marginalised. 
It is uncertain how the country can source enough vaccines to reach a sizeable part of its 
population (ASEAN Briefing, 2021). It is also unknown how other high-risk groups will be 
targeted, e.g. how those with psycho-social disabilities will be vaccinated (especially as almost 
all of them do not have computers, media or phones to access COVID-19 information in their 
psychiatric facilities).5 
Indonesia is culturally diverse with more than 1,300 ethnic groups and six official religions.6 
Over 40% of the population are Javanese.7 However, many ethnic groups have only hundreds of 
members, and are indigenous only to certain regions of Indonesia. Therefore, the range of health 
challenges is daunting, spread across almost 18,000 islands and 730 languages.8 Religious 
 
1 COVAX Commitment agreements (as of 15 December 2020): 
https://www.gavi.org/sites/default/files/covid/pr/COVAX_CA_COIP_List_COVAX_PR_15-12.pdf  
2 WHO (2020). COVAX: Working for global equitable access to COVID-19 vaccines: 
https://www.who.int/initiatives/act-accelerator/covax 
3 Indonesia aims for halal ruling before COVID vaccine roll out. 7 January 2021: 
https://www.aljazeera.com/news/2021/1/7/indonesia-aims-for-halal-ruling-before-covid-vaccine-roll-out  
4 Ekawati A (2021). Indonesia's COVID vaccination campaign prioritizes workers. 22 January 2021. 
https://www.dw.com/en/indonesias-covid-vaccination-campaign-prioritizes-workers/a-56316852  
5 COVID-19 and The Forgotten People (Indonesia). 16 April 2020: 
https://www.internationaldisabilityalliance.org/covid19-indonesia  
6 Widayanti AW, Green JA, Heydon S, Norris P (2020). Health-Seeking Behavior of People in Indonesia: A 
Narrative Review. J Epidemiol Glob Health, 10(1):6-15. DOI: 10.2991/jegh.k.200102.001 
7 World Population Review (2021). Indonesia Population 2021 (Live): 
https://worldpopulationreview.com/countries/indonesia-population  
8 Successes and challenges for health in Indonesia. 5 January 2019: 
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)33258-6/fulltext  
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acceptabilty is a major factor: as Indonesia is the world's most populous Muslim-majority 
country, with 87% reported Muslims, the vaccine has been required to pass halal certification 
prior to use (ASEAN Briefing, 2021).  
Case study: South Africa 
South Africa has so far secured 20 million vaccine doses.9 The first batch is expected to arrive at 
the beginning of February 2021, with vaccine distribution starting approximately two weeks later. 
South Africa expects to acquire doses for approximately 10% of the population through COVAX, 
and has been told it will receive them from April through to June 2021. However, there is no 
detailed timeline for a programme aiming to vaccinate as many as 40 million people (Mwai, 
2021). The Progressive Health Forum of South Africa has criticised the government for their lack 
of planning into how these vaccines are going to be deployed.10 To help with this, the South 
African COVID-19 Vulnerability Index (VIndex) online mapping tool has been developed to 
identify populations that are at multiple risk, and to identify areas where the population are 
considered most vulnerable11 to COVID-19. 
The country wants to vaccinate healthcare workers in the first wave, but with the number of 
workers estimated at 1.2 million, this first batch does not look like it will be enough. The roll-out 
distribution is further compounded by the fact that the vaccines are not currently authorised for 
use in children under the age of 16.12 The second wave would expand the roll-out to essential 
workers (e.g. fire fighters), individuals over 60 years, and people with comorbidities who 
are at particularly higher risk than most. In total, 16.5 million people are targeted in this phase. In 
the third phase, the general population older than 18 years would be the target – a total of 
22.5 million people.13  
3. Social and cultural challenges related to COVID-19 
vaccine roll-out, distribution, and access 
The COVID-19 crisis is not simply a health problem but a societal one: it impacts every single 
person in society one way or another (Rajan et al., 2020). The UN General Assembly calls for 
“the rapid scaling up of manufacturing and establishment of supply chains that promote and 
ensure fair, transparent, equitable, efficient and timely access to drugs and future COVID-19 
 
9 South Africa has been seeking to source vaccines in three ways: via the WHO-backed COVAX Facility scheme, 
led by Gavi, the Vaccine Alliance, WHO and the Coalition for Epidemic Preparedness Innovations (CEPI); via 
arrangements made by the African Union, and through bilateral contracts with vaccine manufacturers. 
10 Progressive Health Forum of SA slams government for delayed procurement of coronavirus vaccines. 4 
January 2021:  https://www.youtube.com/watch?v=uJViqu9hPDk  
11 ‘Vulnerability’ in this context refers to the demographic and socio-economic factors that affect the resilience 
of individuals and communities, and represent those more likely to be adversely affected when COVID-19 
manifests itself (i.e. older people; those with underlying health conditions, and the population at risk such as 
exposed to increased health and social vulnerability – i.e. those who are poor or live in deprived conditions 
which impacts on health and sanitation; those who live in crowded areas or informal settlements which 
impacts on social distancing; and those who live in multi-generational households and large extended 
families in a single dwelling). 
12 SABC News (2021). Government's COVID-19 immunisation plan unattainable Prof Madhi (4 January 2021): 
https://www.sabcnews.com/sabcnews/governments-covid-19-immunisation-plan-unattainable-prof-madhi/  
13 Medical Brief (2021). Madhi: SA has no vaccination strategy, just an unrealistic goal (21 January 2021): 
https://www.medicalbrief.co.za/archives/madhi-sa-has-no-vaccination-strategy-just-an-unrealistic-goal/ 
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vaccines.”14 Therefore, international co-operation remains a matter of necessity for and within all 
nations to ensure equitable distribution of therapies (Bollyky et al., 2020). However, research 
shows concerns about equity in access to COVID-19 vaccines, such as the interplay of ethno-
social-economic factors can hinder vaccine access (Chiriboga et al., 2020):  
Ethnic inequalities 
Ethnic inequalities in access to health services, representation and involvement in the COVID-19 
response are critical to reaching communities at heightened risk of infection, and with limited 
access to treatment (Lenhardt, 2020). Health professionals often frame members of ethnic 
minority communities as “hard-to-reach” because of low engagement in population health 
screenings (Dodds & Fakoya, 2020). However, it is more accurate to say these groups tend to be 
“hardly reached” by those who fail to understand the needs of marginalised people. 
Cultural and religious restrictions 
In some countries, minority ethnic or religious affiliation was associated with vaccination status 
during mass campaigns. For example, results of an evaluation of a mass polio campaign in India 
showed that unvaccinated children were more likely to be Muslims than Hindus, although 
Muslims represent a smaller proportion of the population than Hindus (Singh et al., 1997; Weiss 
et al., 2010: 361). Most religions have no prohibition against vaccinations; however, some have 
considerations, concerns or restrictions regarding vaccination in general, particular reasons for 
declining vaccination, or specific vaccine ingredients.15 
Lack of trust and vaccine acceptability 
Vaccine confidence refers to people not having trust in vaccines and/ or the health system that 
delivers them (Merriam & Behrendt, 2020: 15). Prior to the COVID-19 pandemic, there has been 
a global decline in vaccine acceptability and uptake because of doubts about efficacy and safety, 
and the spread of misinformation about vaccines (Tull, 2019). A 2020 survey conducted by the 
Africa Centres for Disease Control and Prevention (Africa CDC), in partnership with the London 
School of Hygiene & Tropical Medicine (LSHTM) has shown that a predominant majority (79% 
average) of respondents in 15 African countries would take a COVID-19 vaccine if it were 
deemed safe and effective.16 However, before a vaccine is rolled-out, awareness and 
acceptance is crucial. For example, a report by the Infectious Diseases Research Collaboration 
(IDRC) in Uganda shows that religious leaders have claimed that “whites use drugs to cause 
infertility among [black] girls disguised as vaccines for immunisation” (Kamya, 2020: 25). 
Negative social influences by male spouses was another reason provided for not immunising 
children (Kamya, 2020: 22). Therefore, the importance of trusted messengers in encouraging 
behaviour change must be remembered (Merriam & Behrendt, 2020: 56): 
 
14 The United Nations General Assembly (2020). International cooperation to ensure global access to medicines, 
vaccines and medical equipment to face COVID-19.  
15 Immunizations and Religion: https://www.vumc.org/health-wellness/news-resource-articles/immunizations-and-
religion 
16 Majority of Africans would take a safe and effective COVID-19 vaccine – Africa CDC. 17 December 2020: 
https://africacdc.org/news-item/majority-of-africans-would-take-a-safe-and-effective-covid-19-vaccine/ 
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Case study: Indonesia 
Indonesia witnessed a large drop in confidence between 2015 and 2019, partly triggered by 
Muslim leaders questioning the safety of the measles, mumps, and rubella (MMR) vaccine, and 
ultimately issuing a fatwa - a religious ruling - claiming that the vaccine was haram and contained 
ingredients derived from pigs and thus not acceptable for Muslims (de Figueiredo et al., 2020: 
906). 
Cultural discrimination and stigma 
Globally, COVID-19 has also further marginalised historically oppressed and excluded groups, 
such as people living with disabilities (PLWD) (Johns et al., 2020). PLWD often live in 
isolation and are excluded from their communities, the education system, healthcare, and other 
vital services. Some are also hidden away by their families.17 Therefore, PLWD are more likely to 
experience worse discriminatory laws, as well as stigma (Armitage & Nellums, 2020 in McKinney, 
2020).  
Low access to COVID-19 vaccine tests 
WHO states that “Anyone with symptoms should be tested, wherever possible.” However they 
add: “Where testing capacity is limited, tests should first be done for those at higher risk of 
infection, such as health workers, and those at higher risk of severe illness such as older 
people, especially those living in seniors’ residences or long-term care facilities.”18 However, a 
systematic review suggests that ethnic minorities and migrant groups have been less likely to 
implement public health measures, be tested, or seek care when experiencing symptoms due to 
barriers and inequities in the availability and accessibility of care (Sze et al. 2020): 
Case study: South Africa 
South Africa is still in an early phase of its COVID-19 epidemic, which means it will have to keep 
up screening, testing and tracing efforts for many months to come. The targeted testing in South 
Africa differs from the approach of most European governments that have relied on citizens 
coming forward for tests and then tracing their contacts (Cotterill , 2020). The level of testing in 
South Africa has now grown to more than 12,700 tests a day. The country has had more than 
1.44 million cases and almost 44,000 deaths19; in some townships (with mainly Black residents) 
testing has picked up a faster spread of the virus in preparation for the second wave (Cotterill, 
2020; Daniel, 2020). For example, Gauteng, the smallest but most populous province in South 
 
17 ADD International: https://add.org.uk/why-
disability?gclid=CjwKCAiApNSABhAlEiwANuR9YP5plkcWBqmWKTJmNPvxcY-kCzdyodFlXZw967jvUHHU-
vWOivpVWhoCjsoQAvD_BwE  
18 Coronavirus disease (COVID-19) F&Q - When should I get a test for COVID-19? 12 October 2020: 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-
detail/coronavirus-disease-covid-19  
19 WHO Coronavirus Disease (COVID-19) Dashboard: https://covid19.who.int/table  
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Africa, has the highest number of tests,20 and the lowest proportion of adults living in poverty at 
29.3%.21  
Socio-economic status is a factor. The majority of COVID-19 tests have been completed in 
the private sector, however, people can get tested for free at state/public hospitals, community 
clinics, and some pharmacies. Bookings at private doctors/facilities, or at home for a premium 
fee, can be done online. Alternatively, pathology chains will all take samples at various centres 
around South Africa for testing – in some cases as a drive-through service (Daniel, 2020). 
However, this will exclude several minority groups. Some argue that the wealthier provinces in 
South Africa, like Western Cape22, are at an advantage over others in having the infrastructure 
required to an enable test, trace, and isolate (TTI) to be effective. Broadening the remit of TTI 
systems to go beyond COVID-19 alone offers an opportunity to positively engage with younger 
individuals with poor health-seeking behaviour, who might otherwise be unknown to public 
health or healthcare services (Jain et al., 2020). The youth (aged 18–34) constitute almost a third 
of the population (17.84 million) in South Africa,23 the majority are female and Black African. 
Levels of other health conditions such as HIV is also high in younger age women:  
Accessing COVID-19 treatment 
Migrants and refugees in Kenya, Somaliland, and Niger have reported suspicion and mistrust 
growing among the native-born population due to the belief that immigrants are bringing COVID-
19 to their countries (Mixed Migration Centre, 2020a). Interviews conducted with immigrants has 
highlighted their fear of facing racism and discrimination in accessing health services for 
COVID-19 (Mixed Migration Centre, 2020b). For example, an Ivorian woman in Tunisia stated 
that migrants would refrain from going to the hospital if they had a cough due to the fear of 
further stigmatisation. Immigrants in Tunisia also fear that government authorities may prioritise 
Tunisian citizens over immigrants in providing healthcare services, especially in cities with 
significant immigrant and refugee populations. 
Case study: South Africa 
Until now, South Africa has not used any COVID-19 vaccine. Interim results from a Novavax 
vaccine trial that ran separately in South Africa where the B.1.351 (sometimes referred to as 
501Y.V2) variant of COVID-19 has accounted for most infections, found that its efficacy 
dropped from 60.1% to 49.4% when HIV-infected participants were included.24 People living 
 
20 With 370,264 confirmed positive test cases as of 21 January 2021: 
https://www.statista.com/statistics/1108670/coronavirus-cumulative-cases-in-south-africa/  
21 Five facts about poverty in South Africa – data from The Living Conditions Survey (LCS): 
http://www.statssa.gov.za/?p=12075  
22 According to the latest census the Western Cape population is approximately half (49%) formerly classified as 
coloured (mixed race); 33% as "Black African", 17% "White", and 1% "Indian or Asian". There is a long-standing 
feeling among some that in an effort to redress the problems from the past, the democratic government has 
ignored their needs. Race in South Africa: 'We haven't learnt we are human beings first'. 21 January 2021- see 
https://www.bbc.co.uk/news/world-africa-55333625  
23 Statistics South Africa: http://www.statssa.gov.za/?p=12362  
24 Wadman M, Cohen J (2021). Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less 
potent in South Africa. 28 January 2021: https://www.sciencemag.org/news/2021/01/novavax-vaccine-delivers-
89-efficacy-against-covid-19-uk-less-potent-south-africa  
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with HIV/AIDS (PLWHA) are at high risk of COVID-19 if they do not have access to anti-retroviral 
treatment (ART).25 South Africa has the largest number of people on ART worldwide.26 
In January 2021, South African authorities approved the use of a drug used to control parasites 
in humans and livestock to treat COVID-19 patients. The Ivermectin drug will not be limited to 
patients with known COVID-19 co-morbidities. However, Ivermectin will only be used in a 
“compassionate controlled-access programme”, amid drug trials. This will help the regulator to 
monitor its use and collect much-needed safety data (Kew, 2021). However, the roll-out of the 
controlled-access programme has been considered “ethically unjust” by some doctors.27 
4. Impacts of these challenges on excluded and 
marginalised groups 
COVID-19 has had a disproportionate impact on racial and ethnic groups in high income 
countries.28 However, there is a lack of similar data from LMICs. A recent systematic review of 
social inclusion and urban access to healthcare in LMICs found limited consideration to 
intersectional aspects of social inclusion, such as gender, ethnic and religious backgrounds, 
disability, migration status, and age (Mirzoev and Tull et al., in preparation). However, there is 
no clear evidence to confirm or rule out an association between ethnicity and outcome in COVID-
19 is important for regions such as Africa and South Asia, where the pandemic is at an earlier 
stage (Khunti et al., 2020). More research is needed to better understand the impact that COVID-
19 has on Black, Asian, and minority ethnic (BAME) communities (Abuelgasim et al., 2020). The 
following section illustrates  that the majority of research shows that impacts on marginalised or 
excluded groups are negative: 
Hard-to-reach populations 
These people are also known as high risk or marginalised populations. They suffer from a 
number of supply-side barriers to vaccination, including geography, war and conflict, home-
bound mobility limitations, or inadequate vaccination systems (Ozawa et al., 2019). Evidence 
shows an overall negative impact of COVID-19 for groups in a range of social areas: 
Disrupted access to healthcare services 
Barriers to migrants' access to healthcare include issues with GP registration, uncertainty 
about healthcare and migrants' legal status, financial concerns, cultural issues, and clashes with 
staff. If this exclusion continues during the COVID-19 epidemic, it will promote a hostile 
environment for “low skilled” migrants, resulting in the wrongful denial of health services to 
thousands (Dodds & Fakoya, 2020).  
 
25 AVERT - CORONAVIRUS (COVID-19) AND HIV: https://www.avert.org/coronavirus/covid19-HIV   
26 AVERT - HIV AND AIDS IN SOUTH AFRICA (2019): https://www.avert.org/professionals/hiv-around-
world/sub-saharan-africa/south-africa  
27 Comins L (2021). SA doctors livid over Sahpra’s guidelines for Ivermectin use. 29 January 2021: 
https://www.iol.co.za/mercury/news/sa-doctors-livid-over-sahpras-guidelines-for-ivermectin-use-6fac05da-f64d-
4fcd-a5e0-af2ae7fba4ff  
28 For example, in the USA: https://doi.org/10.1093/cid/ciaa815 
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Homeless people are at particular risk from co-morbidities such as tuberculosis. However, the 
impact of the COVID-19 response on care-seeking behaviour among people with tuberculosis is 
unknown. Available data suggests that fewer people are accessing tuberculosis services than 
would usually be expected during the COVID-19 response worldwide,29 including in India30 
and South Africa.31 COVID-19 is also likely to reduce access to tuberculosis diagnostics. 
LQBTQI patients not able to receive hormone therapy for gender dysphoria could result in higher 
levels of mental distress, depression, anxiety or suicidal ideation (Crank, 2020).  
Adverse health outcomes 
Refugees, as well as displaced, undocumented, and stateless people around the world 
would remain vulnerable to COVID-19 if they remain ineligible for inoculations.32 They will be 
more likely to suffer physical and mental health as consequence (Mukumbang, 2020). Such 
disproportionate impact warrants them to be considered a “most-at-risk” population. 
Migrants and refugees are also particularly vulnerable to the impact of COVID-19 in the wider 
community (Kluge et al., 2020). As these populations are mobile, additional risk of COVID-19 
spread will occur, unless they are included in vaccination efforts (IRC, 2021). 
Sex workers are among the most marginalised hard-to-reach groups (Platt, 2020). Sex workers 
who are homeless, use drugs, or are migrants with insecure legal or residency status face 
greater challenges in accessing health services (Kluge et al., 2020).  
PLWD are more likely to experience increased health needs and worse health outcomes; these 
issues are likely to be intensified during the COVID-19 epidemic (Armitage & Nellums, 2020 and 
Kuper et al., 2020 in McKinney, 2020). People with learning disabilities are more likely to have 
other physical health problems, such as obesity and diabetes (Burgess et al., 2020). Certain 
kinds of learning disability, such as Down’s syndrome, can make people more vulnerable to 
respiratory infections, which can increase their risk of dying from COVID-19 (Public Health 
England, 2020):  
Case study: Uganda 
According to the 2002 Population and Housing Census, at least 16% of the population are 
PLWD. Recent research shows that COVID-19 has resulted in limited or absent access to 
medical services and medication for disabled adults and children with chronic illness (Mbazzi 
et al., 2021). This can be due to restrictions in travel, some facilities restricting access (to care or 
information on care), and limited financial resources. Data from the International Disability 
 
29 Louie JK, Reid M, Stella J, et al. (2020). A decrease in tuberculosis evaluations and diagnoses during the 
COVID-19 pandemic. Int J Tuberc Lung Dis, 24: 860-862: https://doi.org/10.5588/ijtld.20.0364  
30 Gupta A, Singla R, Caminero JA, et al. (2020). Impact of COVID-19 on tuberculosis services in India. Int J 
Tuberc Lung Dis, 24: 637-639: DOI: 10.5588/ijtld.20.0212  
31 National Institute for Communicable Diseases. Impact of COVID-19 intervention on TB testing in South Africa: 
https://www.nicd.ac.za/wp-content/uploads/2020/05/Impact-of-Covid-19-interventions-on-TB-testing-in-South-
Africa-10-May-2020.pdf  
32 Debinski G (2021). Vaccine politics and human rights. 13 January 2021: https://www.gzeromedia.com/vaccine-
politics-and-human-rights 
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Alliance persons with albinism (lack the gene to produce melanin) in Jinga, eastern Uganda are 
often not regarded as PLWD, and as a consequence they are left behind in health programmes. 
Their requirements are hardly considered, even in non-emergency settings (IDA, 2020). A main 
impact is that risk of skin cancer for this group increases.  
Socio-economic inequalities 
Refugees, as well as displaced, undocumented, and stateless people are also more likely to 
suffer disproportionate socio-economic consequences of COVID-19 (Mukumbang, 2020). These 
groups have been largely excluded from social protection and resources needed to minimise 
their contracting COVID-19 (Burgess et al., 2020). The increasing economic and financial woes 
of the certain countries have led to governments adopting and frequently changing laws that, in 
many ways, have impacted negatively on the lives of these foreign-born migrants (Mukumbang 
et al., 2020). 
In the longer term, the impact of sex workers not being vaccinated for COVID-19 would result in 
negative economic impacts (Kluge et al., 2020). This can affect different genders and age 
groups. 
Hard-to-vaccinate populations 
Examples of these populations are those who are reachable but difficult to vaccinate. This can be 
due to distrust, religious beliefs, lack of access to available vaccination services, or gender-
based discrimination (Ozawa et al., 2019): 
Disrupted access to healthcare services 
When healthcare systems are overburdened and resources are reallocated to respond to the 
COVID-19 pandemic, this can further disrupt health services unique to the well-being of women 
and girls (UN Women, 2020: 10). The health of women generally is adversely impacted through 
the reallocation of resources and priorities, including sexual and reproductive health services (UN 
Women, 2020: 2). This can make it more difficult for women and girls to receive treatment and 
health services, especially higher risk groups such as pregnant women/girls, and those living 
with HIV, and/or PLWD. The impact of lower access to health services can be higher 
unintended pregnancies in women and girls (Rafaeli & Hutchinson, 2020). Lower access to 
water, sanitation and hygiene (WASH) will also facilitate spreading COVID-19 to other vulnerable 
groups. 
Adverse health outcomes 
Despite the risk of complications and poor perinatal outcomes, pregnant women are not 
recognised as a high-priority group for COVID-19 vaccination.33 The health impacts can be 
catastrophic, especially in rural, marginalised and low-literacy communities, where women are 
 
33 WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply. Version 1.1. 
Nov 13, 2020. World Health Organization, Geneva 2020. 
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less likely to have access to quality, culturally accessible health services, essential medicines, or 
insurance coverage. This may also result in more child mortality. 
According to UNICEF: “Not only are children and young people contracting COVID-19, they 
are also among its most severely impacted victims. Unless we act now to address the 
pandemic’s impacts on children, the echoes of COVID-19 will permanently damage our shared 
future.”34 Vaccinating children is likely to have benefits both direct (protecting children against 
rare severe paediatric cases of COVID-19 and post-infectious conditions such as multi-system 
inflammatory syndrome in children [MIS-C]), and indirect (protecting others by reducing spread) 
(Klass & Ratner, 2021).  
Older people, especially those 65 years old and above who have comorbidities, will have an 
increased admission rate into the intensive care unit (ICU) and mortality if they become infected 
with COVID-19 (Sanyaolu et al., 2020).   
LGBTQI patients are more likely than the general population to be smokers, which could 
compromise their lungs, and make it more difficult to recover from a respiratory illness if they are 
not vaccinated for COVID-19. The impact of not being vaccinated for COVID-19 would increase 
sex workers’ vulnerability to poor health outcomes (Kluge et al., 2020). Data from India shows 
that people living with HIV/AIDS (PLWHA), including LGBTQI people, struggled to access their 
medication. Their points of medication distribution and medical attention have typically been 
government-designated as COVID-19 centres, meaning that immunocompromised people would 
be taking extra risks to go there to collect medication.35 
There is limited data and evidence on the impacts of COVID-19 on PLWD with pre-existing 
health conditions (Rafaeli & Hutchinson, 2020).  
Socio-economic inequalities 
COVID-19 does not discriminate, it can affect rich and poor. However, the impact of COVID-19 
on livelihoods is gendered. Vaccine uptake impacts women's economic and personal security 
(Harman et al., 2020). Being indoors due to ‘lockdowns’36 might prevent the disease from 
spreading, but lack of income and lack of food will very likely pose a much greater threat to life 
and wellbeing (Pesa, 2020). In sub-Saharan Africa, research shows that secondary impacts of 
COVID-19 on women include lack of social protection, land rights, food security and nutrition, 
and lower numbers of female health workers (Rafaeli & Hutchinson, 2020). This can result in 
higher poverty. For example, in South Africa, women (especially those in informal employment) 
 
34 UNICEF - DON’T LET CHILDREN BE THE HIDDEN VICTIMS OF COVID-19 PANDEMIC: 
https://www.unicef.org.uk/press-releases/dont-let-children-be-the-hidden-victims-of-covid-19-pandemic-unicef/  
35 Submission from the Submission by Human Rights Watch, in OHCHR (2020e) Protection against violence and 
discrimination based on sexual orientation and gender identity (pp. 10/25). 
36 ‘Lockdowns’ are an example of a measure which might be effective in wealthy European urban areas, where 
people can easily stock up on a week’s worth of food, and where temporarily unemployed workers can fall back 
on state benefits. Due to international pressure the same measure is being touted in African countries. But a 
tomato vendor in a South African township does not have the same opportunities to ‘stay at home’ to ‘flatten the 
curve’. Being indoors due to ‘lockdowns’ might prevent the disease from spreading, but lack of income and lack 
of food will very likely pose a much greater threat to life and wellbeing (Pesa, 2020). 
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have already suffered severe economic, livelihood, and social impacts from the lockdown that 
was imposed to curb the spread of the virus.37 
Breastfeeding women have been excluded from the Pfizer38, AstraZeneca and Moderna 
vaccine trials, even if they are otherwise eligible (for example if they are a frontline health, social 
care worker, or a residential home carer).39 This could result in wider socio-economic impacts for 
women. 
Rafaeli & Hutchinson (2020) found that girls’ education, and informal employment in sub-
Saharan Africa have all been affected by COVID-19. The “indirect” impact of lack of vaccination 
in children will increase their family toll of parental illness, failing economies, and chronic stress 
(Klass & Ratner, 2021). As a result of COVID-19, older women tend to face lower life incomes 
and also lower pensions, with fewer possibilities to access care for themselves (UN Women, 
2020: 14). 
Historically, minorities and indigenous peoples make up a large share of the workforce in the 
informal sector, with women disproportionately represented (UN, 2018 in Al Saba, 2020: 9). 
There is limited evidence for indigenous peoples, particularly those from smaller or more isolated 
communities (Al Saba, 2020: 3). However, data on minority indigenous people shows that not 
only can they not access up-to-date information about the situation the world is in, they cannot 
afford health clinic fees. Due to COVID-19 lockdown, where everything is locked down including 
all businesses, cheap labour is not always required, resulting in poverty and food insecurity.40 
Social exclusion and violence 
LGBTQI people are among the most vulnerable and marginalised in many societies, and among 
those most at risk from COVID-19.41 COVID-19 has a disproportionate impact on LGBTQI 
persons: “with few exceptions, the response to the pandemic reproduces and exacerbates the 
patterns of social exclusion and violence” (OHCHR, 2020c: 4/25; OHCHR, 2020d). 
5. Lessons learned from previous pandemics and vaccine 
roll-out 
There are potential factors, such as coverage for certain groups, that may never have been fully 
studied in relation to mass immunisation campaigns and, therefore, do not appear in any 
literature (published, unpublished, or grey literature) (Weiss et al., 2009: 364). Africa has good 
 
37 The National Income Dynamics Study - Coronavirus RApid Mobile (NIDS-CRAM) survey: 
https://cramsurvey.org/reports/  
38 However, In November 2020, Pfizer/BioNTech vaccine revised its guidance so that pregnant and breastfeeding 
women can now receive the COVID-19 vaccine.  
39 Hare H, Womersley K (2020). Healthcare workers who breastfeed should be offered the covid-19 vaccine. 
BMJ. 21 December 2020: https://blogs.bmj.com/bmj/2020/12/21/healthcare-workers-who-breastfeed-should-be-
offered-the-covid-19-vaccine/  
40 United Organisation for Batwa Development in Uganda (UOBDU) (2020). Increased hunger and poverty 
among the Batwa amidst COVID-19 in Uganda. Forest People’s Programme. 7 May 2020: 
https://www.forestpeoples.org/en/increased-hunger-and-poverty-for-Batwa-in-Uganda-amid-covid-19  
41 Bachelet M (2020): COVID-19: Targeted actions needed to protect LGBTI people amid pandemic: 
https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=25807&LangID=E   
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experience from its established vaccination campaigns, including using vaccines to counter 
outbreaks such as Ebola and HIV/AIDS; examples can also be taken from eradication of polio, 
measles vaccination programmes, and 2009 H1N1 (swine ‘flu) influenza outbreak. Although 
there is not a Zika vaccine, lessons can also be learned on acceptability research from the Zika 
international emergency in 2015: 
Evidence from research on previous pandemics 
Research from Ebola vaccine clinical trials and vaccination campaigns by the Ebola Vaccine 
Deployment, Acceptance and Compliance (EBODAC) consortium shows that vaccine roll-out 
programmes can be successful. This guidance has been used in several different vaccination 
programmes in order to aid with social inclusion:  
1. Communication (to address misinformation) 
Build local vaccine acceptability and confidence to prevent threats to roll-out 
In 2015, the Vaccine Confidence Project developed the Vaccine Confidence Index (VCI): a 
survey tool used to monitor spatiotemporal trends in vaccine confidence at national and global 
levels (de Figueiredo et al., 2020). De Figueiredo et al. (2020) found a link between religion and 
uptake when exploring barriers to vaccine uptake: the minority religious groups (or those 
refusing to provide their religious belief) who were associated with lower probability of uptake (de 
Figueiredo et al., 2020: 905).  
Ebola: DR Congo’s experience holds vital lessons in distributing the vaccine and gaining the trust 
of those receiving it (Holland, 2020). A second experimental vaccine (Johnson & Johnson, 2-
dose course, given 8 weeks apart) was introduced in DR Congo as an additional tool to extend 
protection against the 2018 virus outbreak – but not until 2019, and only in areas which did not 
have “active Ebola transmission” (Child, 2019). The first (Merck) vaccine, estimated to be 97.5% 
effective, required a single shot. The differing dosing schedules could have eroded already 
fragile trust in response efforts and be difficult to implement in eastern DR Congo, where there 
are large numbers of displaced people and much of the population is highly mobile. A toxic mix 
of deep-rooted insecurity in the region, widespread mistrust over the outbreak, and response 
efforts significantly hampered the bid to halt the spread of the virus. Close collaboration 
with the local government to obtain mutual trust were keys to success in minority group 
research in the DR Congo (Haug, 2018). Community liaison and social science teams can 
also worked with clinical teams to strengthen trust, as they did in Sierra Leone (Dada et al., 
2019). 
Measles & Rubella: Vaccination campaigns have offered relevant insights, e.g. about parents’ 
decisions regarding vaccinating children they do not believe are at serious risk; as well as about 
trust, access, and equity (Klass & Ratner, 2021). Gavi supported a mass vaccination Measles-
Rubella Campaign (MRC) in Bangladesh during January–February 2014. The Expanded 
Program on Immunization developed a variety of information, education and communication 
(IEC) materials that were used from the national level to the community level.  
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Polio: Campaigns have revealed that vaccine acceptance by communities was threatened by 
anti-vaccination movements, conspiracy theories, miscommunication, religious dogma and 
rumours (Rahi & Sharma, 2020). The Global Polio Eradication Initiative (GPEI), a public-
private partnership, led the knowledge efforts to eradicate polio. It worked to ensure 
that communities and individual caregivers were provided with facts about polio and polio 
vaccination, to combat the spread of health misinformation, and ensure that communities and 
caregivers were equipped with the knowledge they need (Mogoatlhe, 2020).  
Zika awareness: Healthcare workers as community champions were not the only source of 
hope; trust in religious doctrine (an external lever of trust), and caregiver groups (networks of 
trust) also played important roles. In particular, WhatsApp was an important means of 
information diffusion, but only within social networks of trust. Information trust was usually high 
but depended on source (Simas et al., 2020: 959).42  
2. Effective community engagement for vaccine roll-out 
(reciprocity, dialogue, and respect) 
Hard-to-vaccinate populations, or individuals facing demand-side barriers to vaccination, need 
better ways to make vaccines acceptable. Community-based education programmes may be 
carried out to raise awareness, reduce distrust, or involve religious leaders to accommodate 
vaccination. Incentives can be deployed to increase the use of vaccination among individuals 
with socio-economic hardship or debilitating time constraints preventing vaccination (Ozawa et 
al., 2019): 
Ebola: The situation in eastern DR Congo was unique: a public health emergency of international 
concern in the middle of a conflict zone marked by weak governance, community violence, and 
forced displacement (Bisca & Bance, 2019). Most people refused to seek help in Ebola 
Treatment Centres due to misinformation about root causes of the disease, and the supposedly 
occult intentions of responders - an estimated 68% of community deaths occurred in private 
homes in 2019, although this decreased to 29% in the 11th outbreak in 2020 (WHO, 2020b).43 As 
these community deaths also posed a major transmission risk, it was no wonder that several 
actors asked public health responders to put communities front and centre in the Ebola 
response.44 Listening to community voices is a good start, but for outreach efforts to be effective, 
consultations with local leaders should translate into tangible improvements in people’s lives 
(Bisca & Bance, 2019).  
Understand ‘communities’ and ‘marginalisation’ in social dynamics  
Ebola: In healthcare, populations or social groups with lower health status - associated with 
social, environmental, biological and/or political determinants of health - are frequently termed 
 
42 However, cultivating hope can, paradoxically, have an adverse impact on healthcare service delivery. 
Associated social impact was found by Simas et al. (2020: 955-956): rejection of clinical diagnosis if they are 
negative; and caregivers of children putting more trust in professionals who offer hope, even if unrealistic.  
43 WHO (2019). Ebola virus disease – Democratic Republic of the Congo. 16 May 2019. World Health 
Organization: https://www.who.int/csr/don/16-may-2019-ebola-drc/en/ ; 18 November 2020: 
https://www.who.int/csr/don/18-november-2020-ebola-drc/en/  
44 Muvudi M (2019). Community involvement is key to eradicating Ebola. 27 February 201. World Bank Blog: 
https://blogs.worldbank.org/health/community-involvement-key-eradicating-ebola   
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‘marginalised’, ‘vulnerable’ or ‘underserved’. There are numerous tensions between these 
notions in the literature (Shelley-Egan & Dratwa, 2019). Using the term ‘communities’ in an 
uncritical and unreflective way threatens to obscure some of the lessons learned from 
Ebola (Wilkinson et al., 2017). In the Ebola response, the use of the term ‘community’ by public 
health agencies - and in the representations of some of those who came forward as ‘community 
leaders’ - glossed over a large range of more salient forms of identity, hierarchy and division in 
social life in the Mano River region, which includes Côte d'Ivoire, Guinea, Liberia and Sierra 
Leone. These include gender, in a region where questions of health and sickness are intimately 
bound up with distinct masculine and feminine realms of knowledge, practice and authority, 
underpinned by gender-specific initiation societies (Wilkinson et al., 2017). Therefore, the 
lesson is not that ‘communities’ can stop epidemics and build trust; it is that 
understanding social dynamics is essential to designing robust interventions and should 
be a priority in public health and emergency planning (Wilkinson et al., 2017). 
Prevent miscommunication with help from the correct community talent 
Ebola: The capacity of ‘community leaders’ or ‘community health workers’ to work across ethnic, 
religious and socio-economic boundaries is often ill-founded, especially when their efforts are not 
remunerated (Wilkinson et al., 2017). 
Social and political relationships need to be taken into account. For example, Kissi, an ethnic 
group from the forest region of Guinea has long running experiences of marginalisation and 
abuse at the hands of whites and other ethnicities (Wilkinson et al., 2017). A system of village 
chiefs and then district officials had been put in place under colonial times, of which people were 
deeply distrustful. Various response partners trying to contain the epidemic had identified 
‘community leaders’ to liaise between them and the ‘community’, however, there was consistent 
and sometimes violent rejection of outside help. Therefore, by asking residents from 26 villages 
who they would trust and nominate to speak on their behalf, a more relevant and respected 
selection was made (including traditional practitioners, heads of the sacred forests, religious 
leaders - Christians and Muslims -, circumcisers, village birth attendants, hunters, youth, returned 
migrants from the city, and elders/older poeple), allowing this Ebola sensitisation strategy to be a 
success. 
Understand social impact on livelihoods 
Ebola: Quarantines have had a disproportionate impact on hard-to-reach groups such as the 
older people, the poor, and people with chronic illness or disability (Rohwerder, 2014). For 
example, the experience of women in Liberia during the Ebola outbreak demonstrates the 
heavier impact on women, especially those working as market traders (Burki, 2020 in Al Saba, 
2020: 9). 
3. Compliance management (supported by innovative 
technology approaches) 
Vaccine compliance management ensures that the targeted are the ones receiving the 
vaccination. In case of a two-dose vaccine, it ensures that those who received the first dose are 
the ones who receive the second dose at the right time. Supply and demand have been 
measured in a variety of ways: 
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Develop and implement innovation in health systems to identify vulnerable groups 
Ebola: Bedford’s (2018b: 4) review of lessons learned from health seeking behaviour during the 
Équateur outbreak of 2018 suggests that any future responses using the vaccine should study 
“perceptions and experiences of the vaccine (as an intervention, its trial status, and how it was 
introduced and rolled-out, i.e. as a ring vaccination) must be carefully documented… after the 
outbreak is declared over.” The Special Populations Assessment Tool from the US Centers 
for Disease Control and Prevention (CDC) can be used as “may help in identifying those groups 
of individuals who require differing messages from the general public information message or 
who cannot be reached through mass communication channels.”45 
Technology can enable countries to track and demonstrate the progress of their vaccination 
programmes and ultimately provide a foundation for re-organising the health system. 
Electronic or digital vaccine registries are a particularly promising tool. They can ensure equitable 
access by identifying sections of communities with limited access to the vaccines. There are 
already a number of African-created and international apps and registries under development 
(Blair in Sisay et al., 2020). For example, a Social Vulnerability Index using census and 
household survey data, when displayed spatially at a sub-county level, may help highlight the 
location of the most vulnerable households and populations (Stanturf et al., 2015).  
Active case finding and contact tracing activities played a major role in controlling the 2014–2016 
Ebola epidemic, which devastated communities in West Africa.46 However, disease surveillance 
was consistently challenged by low levels of reported alerts, particularly among deaths in DR 
Congo. Despite these challenges, multi-sectoral co-ordination was strengthened, and 
surveillance and investigation activities were enhanced (WHO, 2020b).  
Those working in/with the programme also need to be managed: for example, the WHO 
struggled to trace and vaccinate health workers who operated small, unregistered facilities 
scattered throughout the forests of the eastern DR Congo (Maxmen 2019). The EBODAC Gap 
Analysis Tool checks for capacity building of staff and stakeholders include specific trainings in 
Communication, Community Engagement and Compliance Management (3C) for Ebola vaccine 
deployment for special cadres or groups.47 These “special groups” include traditional healers, 
which may pose a high risk of contracting and passing on the disease, so these need to be 
included in the compliance management (Sisay et al., 2020: 11).  
Measles: Two different surveillance systems in South Africa enabled the 1996-1997 campaign to 
reach children who had not previously been vaccinated (i.e. the ‘hard to reach’), especially in 
Mpumalanga where Blacks/Africans represent the largest ethnic group (89%) (Uzicanin et al., 
2002). In response to the 2004 outbreak in Liberian refugees, two mass vaccination campaigns 
targeting children aged between 6 months and 15 years were held at all 19 transition camps 
 
45 CDC CERC. Crisis & Emergency Risk Communication (CERC) Special populations assessment (pp.1): 
https://emergency.cdc.gov/cerc/resources/pdf/specialpopulationsassessment.pdf  
46 2014 Ebola Outbreak in West Africa—Reported Cases Graphs 2016: 
https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/cumulative-cases-graphs.html 
47 EBODAC (2019). EBOLA VACCINE COMMUNICATION, COMMUNITY ENGAGEMENT AND COMPLIANCE 
MANAGEMENT (3C) GAP ANALYSIS TOOL. “Special cadres or groups” may include: the media, armed forces, 
community influencers, traditional healers, burial groups, cross border stakeholders, etc.(pp.87): 
https://www.worldvision.ie/sites/worldvision.ie/files/pdf/EBODAC-3C-Gap-Analysis-Tool.pdf   
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(TCs) in Côte d’Ivoire (Kouadio et al., 2009). In addition to monitoring average vaccination 
coverage statistics, metrics of spatial heterogeneity (i.e. uneven distribution within an area) 
was used to determine the success of immunisation programmes, as well as risk of disease 
persistence (Brownwright et al., 2017). For displaced populations, a Diseases Surveillance 
Team (DST) was established to perform active surveillance in order to detect cases of rash or 
fever in the early phase, and to take timely control action.  
Use surveillance systems from other vaccination roll-outs for vulnerable groups 
Nationally or regionally integrated vaccine information tracking systems could help improve 
vaccination coverage for people who move around (e.g. migrants or nomadic groups), or for 
individuals who are not consistently receiving health care provider recommendations (Ozawa et 
al., 2019):  
Polio: GPEI had an extensive testing strategy that used community and family engagement, 
science and research, as well as its own control systems. One of them was district 
microplanning48 priority plans using current health facility data, which was key in reaching 
remote and high-risk populations. This strategy has helped keep India polio-free for five years. 
GPEI’s teams in Nigeria, meanwhile, used polio surveillance systems that identifed new cases 
and where they originate (Mogoatlhe, 2020). Existing female health workers in particular played 
a critical role in this effort: they travelled by every form of transportation imaginable to reach 
children in remote locations and from mobile populations, and figured out how to reach 
children in regions rife with conflict and insecurity (Ghai, 2021). 
Measles & Rubella: The Mewat District of north-western India is also using microplanning to 
increase its rates of vaccination against measles and rubella.49  
Regular testing and sampling to identify priority groups 
H1N1 swine ‘flu: If members of the public at high risk of death from influenza are prioritised for 
vaccination, then proportionate supplies of vaccine were distributed according to incidence of 
risk factors, such as certain chronic illnesses. By contrast, if vaccine was distributed in 
amounts proportional to area population rather than to risk, priority groups may not have been 
reached as needed (DeBruin et al., 2012). 
Polio: In order to help prevent massive outbreaks, GPEI and its partners established sampling 
sites in areas that are prone to outbreaks (Mogoatlhe, 2020). Environmental surveillance, 
which involves testing sewage or other environmental samples for the presence of poliovirus, 
helped confirm polio cases in the absence of symptoms like acute flaccid paralysis (AFP).50 
Doctors and health care workers in high-risk areas regularly tested children, while local 
governments tested water sources like rivers for polio-causing bacteria. 
 
48 WHO-UNICEF (2009). Microplanning for Immunization Service Delivery - Using the Reaching Every District 
(RED) Strategy: https://www.who.int/immunization/sage/9_Final_RED_280909.pdf  
49 Global Polio Eradication Initiative (2019). Five ways the fight against polio is a fight against other diseases. 10 
May 2019: https://polioeradication.org/news-post/five-ways-the-fight-against-polio-is-a-fight-against-other-
diseases/  
50 Garcia D (2019). 5 ways our work against polio fights other diseases. 17 April 2019. Rotary: 
https://www.endpolio.org/5-ways-our-work-against-polio-fights-other-diseases  




Collaboration between the private sector, academia, government, and civil society is also 
important (Sadlier, 2020):  
Awareness of positive and negative outcomes in collaborations 
Measles & Rubella: The government included village elders and religious preachers to 
achieve success in Mewat, north east India, to quash rumours that the vaccination would make 
children sterile. By the time the eight-week programme came to an end, 99.01% of the state 
target was achieved.51 
Involve surrounding communities in public health interventions 
Measles: As refugee camp residents may visit neighbouring villages or other camps (i.e. 
Tanzania Kibondo District camp had a central health facility that is used by residents of the camp 
and surrounding villages), extending the programme for both refugees and non-camp residents 
from surrounding areas was crucial in preventing further outbreaks (Kamugisha et al., 2003). 
Establish social relationships with communities 
Ebola: A critical step is to begin with a more realistic account of local social relationships. 
Including anthropologists with specialist knowledge of people and contexts in policy formation 
and implementation can assist this process. A ‘one size fits all’ approach and public meetings 
with supposed key stakeholders is not enough. To achieve the post-Ebola aims of a trusting 
public and strong resilient health systems, more nuanced approaches were needed, which were 
sensitive to how social, political and economic interests interact in policy processes and local 
settings (Wilkinson et al., 2017). 
Measles & Rubella: Additionally with IEC materials, the EPI held advocacy meetings with 
Bangladesh Medical Association (including with renowned medical professionals), and the 
Pediatric Association, to advise them of the MRC and to seek their support, including for 
disseminating information to parents (Sarma et al., 2019). Confirmed measles incidence 
decreased 82%, including in hard-to-reach populations.52 
Use multiple local logistical options to hard-to-reach groups 
Ebola: The WHO used only local DR Congo healthcare workers to distribute the vaccine in a 
subsequent outbreak in the west, which ended in six months with 55 deaths (Holland, 2020). 
Between 2018-20, health workers inoculated more than 400,000 people in three Ebola outbreaks 
in DR Congo, carrying vials colder than an Antarctic winter (60-80 degrees Celsius) across warm 
forests, and along mud-clogged mountain roads. When cars could not pass (i.e. due to roads 
 
51 Quelling rumours to immunise children in Mewat. 14 December 2018: https://www.hindustantimes.com/india-
news/quelling-rumours-to-immunise-children-in-mewat/story-zB2MiY88o26mVjfabQlJCO.html  
52 Khanal S, Bohara R, Chacko S, et al., (2017). Progress Toward Measles Elimination — Bangladesh, 2000–
2016. Weekly / July 21, 2017 / 66(28);753–757: https://www.cdc.gov/mmwr/volumes/66/wr/mm6628a3.htm  
   
 
20 
without bridges flooded), they drove motorbikes. If water was the only way, they used canoes 
(Holland, 2020). 
Lessons learned for COVID-19 vaccine roll-out strategies 
Achieving global, equitable access to COVID-19 vaccines and therapeutics will be difficult 
(Bollyky et al., 2020). The challenge with a prioritised distribution scheme relates to the need for 
data to guide distribution (DeBruin et al., 2012: 588). Roll-out of the COVID-19 vaccine is likely to 
be unique by prioritising adults over children (Blair in Sisay et al., 2020: 8). Based on previous 
pandemics, plans are beginning to emerge for ensuring the equitable worldwide distribution of 
COVID-19 vaccines and therapeutics resulting from biomedical innovations:  
Speed of vaccination is important in curtailing COVID-19: 
The WHO was heavily criticised for its “sluggish” response to the August 2018 Ebola outbreak 
(the second worst in recorded history in the DR Congo) 13 months after the outbreak (Child, 
2019).  
Not all traced people will be vaccinated: 
Findings from the Proceedings of the National Academy of Sciences of the United States of 
America (PNAS) report (Wells et al., 2019: 10180; Lenhardt, 2020) assumed that all contacts 
identified in contact tracing in the DR Congo Ebola outbreak were vaccinated, although in 
practice the vaccination is only administered to those over the age of 18 years and not 
pregnant, breastfeeding, or severely ill, which indicates limitations of vaccination for certain 
vulnerable groups, as well as only those who consent to the vaccination.  
Combined ring and community vaccination strategies can be successful: 
MSF stated that the WHO’s vaccination strategy no longer made sense because tracing contacts 
of people with Ebola has proven so difficult. 20% or more of close contacts could not be reached 
or refused vaccination (Chowell et al. 2019). Around half of all people diagnosed with Ebola 
during the 2018 outbreak were not identified as contacts of the sick before they themselves 
became ill - and so never received the vaccine (Child, 2019). Therefore, a “third ring” community-
level vaccination that targeted members of communities even if they are not known contacts of 
Ebola cases was needed (Chowell et al. 2019). MSF recommended that Ebola responders 
should instead vaccinate the population widely in Beni, north eastern DR Congo, and other 
areas where Ebola has spread for months (Maxmen, 2019). Therefore, if levels of inaccessibility 
exceed approximately 10% in the context of significant delays to vaccinating contacts, a 
combined ring and community vaccination strategy is effective until the levels of inaccessibility 
exceed approximately 50% (Chowell et al. 2019). 
Expand categories of at-risk groups 
Consider including eligible pregnant women and children: 
There is currently no evidence that the COVID-19 vaccine is unsafe during pregnancy. Both 
Pfizer and Moderna recently began new vaccine trials including children as young as age 12 
years old. 
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Pregnant women represent a vulnerable group, often overlooked during epidemics, as recently 
seen during the Ebola outbreaks. During the Ebola epidemic in Sierra Leone, fewer pregnant 
women accessed healthcare, and among those who did there were increased rates of maternal 
mortality and stillbirth. In DR Congo, to direct women to places which were not seen as an 
infection risk, libraries and schools were repurposed to offer maternal health services during 
its recent Ebola epidemic (Burki, 2020). The programme in DR Congo was approved for 
expansion to younger age groups in the first half of 2019,53 as both UNICEF and Save the 
Children found that children were more likely to die from the disease than adults.54 
Donated H1N1 vaccination population coverage varied from 0.4% to 11%, with a median 
coverage of 4%. However, all countries targeted pregnant women (21%, range, 4%–72%) and 
healthcare workers (9%, range 1%–73%). Fourteen of 19 countries targeted persons with 
chronic conditions, and 10 of 19 countries vaccinated children (Mihigo et al., 2012).  
Prevent maternal mortality and morbidity and stillbirth 
Healthy women of childbearing age, newborn babies and infants are generally considered to be 
less severely affected by COVID-19 than other age groups. The debate over COVID-19 vaccines 
has (rightfully) focused on discovery and development, vaccine hesitancy, and equitable access 
(Harman et al., 2020): 
Past pandemics have shown increased rates of maternal mortality and morbidity, adolescent 
pregnancies, and HIV and other sexually transmitted diseases. Multiple and intersecting 
inequalities, such as ethnicity, socio-economic status, disability, age, race, geographic 
location and sexual orientation, among others, can further compound these impacts (UN 
Women, 2020; 10).  
During the Ebola epidemic in Sierra Leone, fewer pregnant women accessed healthcare, and 
among those who did there were increased rates of maternal mortality and stillbirth (Burki, 
2020). In DR Congo, pregnant and lactating women were initially excluded from the Merck EVD 
vaccine compassionate use protocol used in North Kivu, out of concerns that women could 
spontaneously abort or that infants could be harmed. Some of the excluded women were high-
risk contacts, but were not permitted to receive the vaccine, despite operational research 
showing that they understood the risks and would prefer to be given the choice about whether to 
take the vaccine (Rohan & McKay, 2020). 
Continue child vaccination programmes 
There is a real threat of vaccine-preventable disease outbreaks because of COVID-19 related 
disruptions to routine immunisation (IRC, 2021): 
 
53 ReliefWeb Report (2019). UNICEF DR Congo Ebola Situation Report North Kivu and Ituri—03 February 2019: 
https://reliefweb.int/report/democratic-republic-congo/unicef-dr-congo-ebola-situation-report-north-kivu-and-ituri-
03; Ilunga Kalenga O, Moeti M, Sparrow A, et al. (2019). The Ongoing Ebola Epidemic in the Democratic 
Republic of Congo, 2018–2019. The New England Journal of Medicine, Epub 2019/05/30.  
54 DRC Ebola impact getting worse for children. 7 August 2019: https://www.cidrap.umn.edu/news-
perspective/2019/08/drc-ebola-impact-getting-worse-
children#:~:text=The%20agency%20noted%20that%201,impact%20on%20kids%20has%20increased.  
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Children are unlikely to be the first recipients of COVID-19 vaccine, as they generally are in 
malaria immunisation programmes (Blair in Sisay et al., 2020: 7). Children aged five years and 
younger are the most vulnerable age group affected by malaria, although this age group has 
been relatively spared from COVID‐19 mortality and severe morbidity so far (Anjorin et al., 
2020). Multiple immunisation programmes running concurrently with COVID-19 
vaccination will have long-term benefits. National immunisation programmes globally are at 
risk of suspension due to the severe health system constraints and physical distancing measures 
in place to mitigate the ongoing COVID-19 pandemic. Benefit–risk analysis has concluded that 
routine childhood immunisation should be sustained in Africa as much as possible during the 
COVID-19 pandemic (Abbas et al., 2020). 
Global and national co-operation for increased uptake 
International co-operation and assistance between developed and developing countries is crucial 
in ensuring that all relevant health technologies, intellectual property data and know-how on 
COVID-19 vaccines and treatment are widely shared as a global public good (OHCHR, 2020a). 
Global solidarity is needed to tackle COVID-19 successfully: 
Each country that was a potential recipient of vaccine was asked to draw up a National 
Deployment and Vaccination Plan (NDVP) for A(H1N1)pdm09 vaccination in line with the 
Strategic Advisory Group of Experts (SAGE) recommendations, which included vaccination for 
healthcare workers, pregnant women, and persons with chronic diseases, as well as for children 
and other groups of individuals who may have been prioritised by the country.55 
Update policies for universal health coverage (UHC) 
UHC is needed in order to leave no-one behind in COVID-19 treatment: 
WHO antiretroviral therapy (ART) guidelines have evolved from “treating the sickest” to “treating 
all” (Assefa et al., 2020). This has achieved successes in increasing ART coverage in all 
populations and locations. However, global data has shown inequity in ART coverage: 
women (68%) versus men (55%), and adults (62%) versus children (54%) (Assefa et al., 2020). 
This inequity has widened over time, and with expanded ART eligibility criteria. Although, data 
from at least one high-burden country (Ethiopia) shows that inequity among regions has 
narrowed over time. This is due to the improvements in the primary health care systems and 
implementation of the more inclusive public health approach. 
Overcome cultural barriers to healthcare 
Consider racism, including community and institutionalised racism 
To achieve equitable coverage of COVID-19 vaccinations, former or existing prejudices must be 
considered: 
 
55 Strategic advisory group of experts on immunization—report of the extraordinary meeting on the influenza 
A(H1N1) 2009 pandemic. 7 July 2009. Wkly Epidemiol Rec, 2009, 84, 301-304. 
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It is often the most marginal and vulnerable groups who are systematically ignored and not 
reached by biomedical interventions (Wilkinson et al., 2017). Reasons for resistance are multiple, 
ranging from contradictory messaging, unsafe and degrading conditions in hospitals, and 
histories of violence, extraction (bribery) and corruption - which fed fears that Ebola (or the 
chlorine disinfectant spray) was a means of ethnic cleansing (Wilkinson et al., 2017).  
Improve socio-cultural perceptions of vaccination 
Train health professionals to explain COVID-19 risks to vulnerable groups: 
Communication around the vaccine is crucial as negative community perceptions and 
understandings of why some people are vaccinated and others not, augments social risks 
associated with “distrust, suspicion and stigmatization” (Alcayna-Stevens, 2018: 29). Health care 
workers also need to be mindful not to engage in discriminatory practices and improve 
immunisation recommendations (Ozawa et al., 2019):  
Faced with many issues related to language and culture, beginning with understanding and 
communicating perceptions of Ebola risk, vaccination and treatment helped with the marginalised 
and vulnerable BaTwa population of Équateur, DR Congo (Haug 2018). BaTwa are also referred 
to as Historically Marginalized Peoples (HMPs) as they are culturally different from the rest of the 
country, although this label has been criticised.56 The BaTwa group lives interdependently with 
agricultural Bantu57-speaking populations in Burundi, eastern DR Congo, Rwanda, Tanzania, 
and Uganda. The Batwa minority indigenous community were labelled as transmitters of the 
disease, and experienced discrimination in their access to health services from the staff (Bedford 
2018a, Duda et al. 2018). In order to inform the BaTwa about protecting their health, UN 
surveillance and risk communication teams accompanied Bantu acquaintances which the 
Batwa villagers had previously met and trusted.  
Between 1999 and 2008, the CORE Group Polio Project (CGPP) trained 250,000 “mobilizers” 
(including community health workers, community leaders, and lay supporters in the 
community) to provide essential, culturally relevant information about polio to mothers and 
caretakers as part of the GPEI to access the “chronically unreached, marginalized and most 
vulnerable populations in the world” (Losey et al., 2019). The percentage of children younger 
than five years of age who were missed in any supplemental immunisation activity in Nigeria 
decreased from 4.5% to 1.5%. In India, the percentage of houses missed decreased from 5.9% 
to 4.4%. 
Understand religious concerns with vaccines 
The COVID-19 vaccine must be available for use by all religious groups: 
A halal (acceptable to Muslims) vaccine was the main factor that determined Malay participants’ 
decision to accept vaccination uptake of the 2009 H1N1 influenza vaccine in a multi-ethnic Asian 
population of Malaysia (Wong & Sam, 2010). In 2018, the Indonesian Ulema Council, the Muslim 
 
56 Nsanzimana G (2019). “Are We Batwa or ‘Historically Marginalized People’?”: 10 June 2019: 
https://www.chronicles.rw/2019/06/10/are-we-batwa-or-historically-marginalized-people/  
57 ‘Bantu’ refers to a linguistic family that includes Twa. 
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clerical body that issues certifications that a product is halal, or permissible under Islamic law, 
decreed that the measles and rubella vaccines were “haram,” or unlawful, because of the 
pork-derived gelatin used as a stabiliser. Measles cases subsequently spiked, giving 
Indonesia the third-highest rate of measles in the world. A decree was later issued by the Muslim 
clerical body saying it was permissible to receive the vaccine, however, cultural taboos still led to 
continued low vaccination rates.58  
Overcome socio-political barriers to healthcare 
Political support for COVID-19 vaccination roll-out is important: 
The findings of declining vaccine confidence in Afghanistan, Azerbaijan, Pakistan, and Nigeria 
mirrored trends in political instability and religious extremism in these settings (de Figueiredo et 
al., 2020: 906). Therefore, successful immunisation campaigns must secure the support of the 
existing political leaders. In Somalia, the terrorist group al-Shabaab had forbidden polio workers 
from operating in areas under their control, viewing vaccination campaigns as part of a foreign 
campaign to impose a centralised government. One million children were unvaccinated between 
2010 and 2013, when a polio outbreak occurred. Since then, immunisation campaigns have 
improved their access to rebel-controlled areas by employing locally recruited staff to work 
within their own clans, and negotiate access with local-level militant leaders (Kennedy & 
Michailidou, 2016).  
Overcome socio-economic and socio-political barriers to health 
The impacts of COVID-19 to date have been significant on health, the economy and society (e.g. 
occupation, education, wealth, and housing): 
Achieving global equitable vaccination will boost economies, improve global health security, and 
help achieve the Sustainable Development Goals (SDGs): not just those related to health, but 
also poverty, inequalities, education, and more.59 However, vaccination coverage is not uniform 
across various socio-economic groups (Ndwandwe et al., 2018). 
Across many parts of the world, governments, humanitarian responders and communities 
confront multiple challenges where the response to public health emergencies must compete for 
human, financial and health service resources (Carter et al., 2020). However, many people in 
vulnerable groups – including hard-to-reach or hard-to-vaccinate populations - have little 
confidence that their government will protect them from COVID-19 (Burgess et al., 2020). 
Governments must take all measures necessary to ensure that COVID-19 medical products are 
affordable, equitably accessible by vulnerable and marginalised groups, and distributed 
according to public health need. This will require governments to set clear guidelines for the fair 
and equitable distribution of treatments for their own populations (Bollyky et al., 2020): 
 
58 Concern among Muslims over halal status of COVID-19 vaccine. 20 December 2020: 
https://www.independent.co.uk/news/concern-among-muslims-over-halal-status-of-covid19-vaccine-muslim-
covid-law-vaccine-novartis-b1776700.html 
59 Moving towards equitable access to vaccination - The Lancet Infectious Diseases: 
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30487-6/fulltext 
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Share vaccine supplies with LMICs and monitor for equality 
The COVID-19 virus has spread fast, and caused huge socio-economic changes across the 
globe. Therefore, international collaboration is needed for equitable distribution of vaccines: 
During the 2009 H1N1 pandemic, wealthy nations bought virtually all vaccine supplies. Even 
after the WHO appealed for donations, supplies for LMICs were limited (Bollyky et al., 2020). To 
provide vaccination against infection due to the 2009 pandemic influenza A virus subtype H1N1 
A(H1N1)pdm09 to resource-constrained countries with otherwise very little access to the 
A(H1N1)pdm09 vaccine, the WHO co-ordinated distribution of donated vaccine to selected 
countries worldwide. Bangladesh was due to receive the largest share: 12.6 million doses. From 
February through to November 2010, 32.2 million doses were delivered to 34 countries in Africa. 
Data from these surveillance systems from 2010–2012 showed that influenza A(H1N1)pdm09 
circulated in West Africa later than in other regions of the continent. Several countries throughout 
western Africa captured young children, but lacked data on adults and older people.60 A 
number of African countries have provided regular updates to WHO on the spread of influenza 
A(H1N1)pdm09, however, the impact of the pandemic on the African continent is not apparent.61 
Therefore, this indicates a need to strengthen surveillance systems to assess the effect of the 
pandemic and monitor the impact of influenza in general. 
  
 
60 Nzussouo, N.T., Duque, J., Adedeji, A., et al. (2017). Epidemiology of influenza in West Africa after the 2009 
influenza A(H1N1) pandemic, 2010–2012. BMC Infect Dis, 17, 745: https://doi.org/10.1186/s12879-017-2839-1  
61 WHO – Africa Flu Alliance: https://www.who.int/influenza/preparedness/africa_flu/en/  
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